| 1例肺癌合并3级贫血患者应用贝伐珠单抗的药学监护 |
| |
| 引用本文： | 吴端仪,曾卫强,劳海燕,何杏仪.1例肺癌合并3级贫血患者应用贝伐珠单抗的药学监护[J].肿瘤药学,2021,11(6):758-762. |
| |
| 作者姓名： | 吴端仪 曾卫强 劳海燕 何杏仪 |
| |
| 作者单位： | 1.广州中医药大学顺德医院 临床药学科，广东 佛山，528300;2.广东省人民医院/广东省医学科学院 药学部， 广东 广州，510080 |
| |
| 摘 要： | 识别和分析药物不良反应是临床药师工作的切入点之一。鉴于目前未见肺癌合并3级贫血患者使用贝伐珠单抗的安全性报道，本文报道1例临床药师对肺癌合并3级贫血患者使用贝伐珠单抗维持治疗的药学监护，为临床医师提供治疗参考。临床药师从药学的角度分析贝伐珠单抗的血液学毒性，并为患者提供全面的药学监护，促进合理用药。
|
| 关 键 词： | 临床药师 药学监护 贝伐珠单抗 贫血 |
| 收稿时间： | 2019/11/16 0:00:00 |
Pharmaceutical care on one patient with lung cancer and grade 3 anemia treated with bevacizumab |
| |
| WU Duanyi,ZENG Weiqiang,LAO Haiyan,HE Xingyi.Pharmaceutical care on one patient with lung cancer and grade 3 anemia treated with bevacizumab[J].Anti-Tumor Pharmacy,2021,11(6):758-762. |
| |
| Authors: | WU Duanyi ZENG Weiqiang LAO Haiyan HE Xingyi |
| |
| Institution: | 1.Department of Clinical Pharmacy, Shunde Hospital Guangzhou University of Chinese Medicine, Foshan, Guangdong, 528300, China;2.Department of Pharmacy, Guangdong Provincial People''s Hospital/Guangdong Academy of Medical Sciences, Guangzhou, Guangdong, 510080, China |
| |
| Abstract: | Adverse drug reaction identification and analysis is one of the entry points for clinical pharmacists. Since there is no report on the safety of bevacizumab used in patients with lung cancer and grade 3 anemia, here we reported a case of successful pharmaceutical care for a patient with lung cancer and grade 3 anemia during the maintenance treatment of bevacizumab, so as to provide a therapeutic reference for clinicians. The clinical pharmacist analyzed the hematotoxicity of bevacizumab from the perspective of pharmacy, gave patients comprehensive pharmaceutical care, and promoted rational drug using. |
| |
| Keywords: | Clinical pharmacist Pharmaceutical care Bevacizumab Anemia |
|
| 点击此处可从《肿瘤药学》浏览原始摘要信息 |
| 点击此处可从《肿瘤药学》下载免费的PDF全文 |
|
